Bridgeway Capital Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,713
Closed -$105K 1231
2024
Q4
$105K Sell
15,713
-494
-3% -$4.35K ﹤0.01% 1103
2024
Q3
$163K Buy
16,207
+1,667
+11% +$24.3K ﹤0.01% 1105
2024
Q2
$227K Sell
14,540
-8,000
-35% -$134K 0.01% 1028
2024
Q1
$494K Hold
22,540
0.01% 936
2023
Q4
$436K Hold
22,540
0.01% 975
2023
Q3
$416K Sell
22,540
-3,993
-15% -$71.9K 0.01% 932
2023
Q2
$490K Buy
26,533
+3,706
+16% +$87.7K 0.01% 906
2023
Q1
$661K Buy
22,827
+16,334
+252% +$435K 0.02% 817
2022
Q4
$180K Hold
6,493
﹤0.01% 1109
2022
Q3
$356K Sell
6,493
-11,667
-64% -$640K 0.01% 987
2022
Q2
$997K Hold
18,160
0.02% 728
2022
Q1
$673K Buy
18,160
+6,000
+49% +$214K 0.01% 867
2021
Q4
$295K Sell
12,160
-3,000
-20% -$100K 0.01% 1104
2021
Q3
$682K Sell
15,160
-3,333
-18% -$140K 0.01% 942
2021
Q2
$863K Sell
18,493
-2,667
-13% -$136K 0.02% 910
2021
Q1
$1.17M Buy
+21,160
New +$1.29M 0.02% 802

Other funds holding OPTN

Bridgeway Capital Management's OPTN Position: Q1 2025 in Review

Bridgeway Capital Management sold out of OptiNose (OPTN) in Q1 2025, closing a stake of 15,713 shares — an estimated $105K sold.

Bridgeway Capital Management first reported a position in OPTN in Q1 2021 and held it in 16 quarters. The position peaked at $1.17M in Q1 2021. 43 funds tracked by Wall St. Rank hold OPTN as of Q1 2025.

  • Bridgeway Capital Management reported no remaining OptiNose position as of Q1 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 15,713 OptiNose shares in Q1 2025, an estimated $105K.
  • Bridgeway Capital Management first reported a position in OptiNose in Q1 2021 and held it in 16 quarters.
  • Bridgeway Capital Management's OptiNose position peaked at $1.17M in Q1 2021.
  • 43 funds tracked by Wall St. Rank held OptiNose as of Q1 2025.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.